Acceptability and engagement amongst patients on oral and intravenous bisphosphonates for the treatment of osteoporosis in older adults

Author:

Narayanasamy Melanie12,Bishop Simon34,Sahota Opinder5,Paskins Zoe67ORCID,Gittoes Neil8,Langley Tessa92

Affiliation:

1. Centre for Rehabilitation & Ageing Research , School of Medicine, , Nottingham, UK

2. University of Nottingham , School of Medicine, , Nottingham, UK

3. Organisational Behaviour and Human Resource Management , Nottingham University Business School, , Nottingham, UK

4. University of Nottingham , Nottingham University Business School, , Nottingham, UK

5. Geriatric Medicine, Nottingham University Hospitals NHS Trust , Nottingham, UK

6. Primary Care and Health Sciences , School of Medicine, , Staffordshire, UK

7. Keele University , School of Medicine, , Staffordshire, UK

8. Department of Endocrinology, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK

9. Division of Epidemiology and Public Health , School of Medicine, , Nottingham, UK

Abstract

Abstract Background Osteoporosis is common in older adults leading to fragility fractures at enormous individual and economic cost. Improving long-term adherence with bisphosphonate treatments reduces fracture risk, but adherence rates for first-line oral bisphosphonate alendronate remains low. Although alternative treatment regimens, including annual intravenous infusions are available, patient acceptability remains unclear. Therefore, understanding patients’ acceptability and engagement in different bisphosphonate regimens is important to ensure optimal treatment benefits. Methods Semi-structured interviews were conducted with 78 patients with a mean age of 69.9 years, who had taken or received bisphosphonates for osteoporosis within the last 24 months. Data analysis included iterative categorisation and used the theoretical framework of acceptability (TFA) to compare the acceptability of treatments regimens. Results Treatment acceptability and engagement were influenced by the extent to which patients understood the prescribed treatment, and evidence of the treatment working. Acceptability and engagement were compromised when treatment was perceived as burdensome, personal costs were incurred, and patients’ values were incompatible with the regimen. The balancing of these factors contributed to patients’ ability to cope with the treatment and their emotional responses. Intravenous treatment was generally perceived as easier to understand, more effective, less burdensome with fewer opportunity costs, and a preferable regimen compared with oral bisphosphonates. Conclusions Annual intravenous zoledronate bisphosphonate treatment was generally more acceptable to patients, perceived as more straightforward to engage in, although a small portion of patients on oral bisphosphonates were satisfied with treatment. Further research is needed to identify how acceptability and engagement can be optimised.

Funder

National Institute for Health and Care Research

Health Technology Assessment

Publisher

Oxford University Press (OUP)

Subject

Geriatrics and Gerontology,Aging,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3